Search

Your search keyword '"Shah, Payal"' showing total 1,010 results

Search Constraints

Start Over You searched for: Author "Shah, Payal" Remove constraint Author: "Shah, Payal"
1,010 results on '"Shah, Payal"'

Search Results

202. Abstract LB052: Cell cycle synchronization: Biomarker analysis in a phase I trial of alternating ribociclib and paclitaxel in advanced breast cancer

203. Abstract 112: Analytical performance of a cfDNA-based targeted methylation multi-cancer early detection test for population-scale screening

211. Hypoglycemia in the Hospital and in the U.S. Population

215. Combination of PARP and ATR inhibitors (olaparib and ceralasertib) shows clinical activity in acquired PARP inhibitor-resistant recurrent ovarian cancer.

216. Phase I experience with first in class TnMUC1 targeted chimeric antigen receptor T-cells in patients with advanced TnMUC1 positive solid tumors.

218. A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer

228. A cross‐sectional survey of dermatologists: assessing practice patterns in sexually transmitted infections.

229. Autonomically-mediated decrease in microvascular blood flow due to mental stress and pain in sickle cell disease: A target for neuromodulatory interventions.

230. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.

231. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

232. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

233. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

234. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.

235. Assisting and empowering women facing natural disasters: drawing from Security Council resolution 1325.

237. Abstract PD9-10: Investigating the clinical utility of tumor mutational burden in predicting rapid progression and death in patients with metastatic breast cancer

238. Abstract PD9-11: Identifying breast cancer survivors with dormant disseminated tumor cells: The PENN-SURMOUNT screening study

239. Abstract PS11-10: A Phase 1b/2 Study of the BET inhibitor ZEN003694 in combination with talazoparib for treatment of patients with TNBC without gBRCA1/2 mutations

242. TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

243. Loss of alpha‐globin genes in human subjects is associated with improved nitric oxide‐mediated vascular perfusion

247. Acceptability of artificial intelligence-based retina screening in general population.

248. Common Microbes and Antibiotic Resistance in Ocular Infections at an Urban Public Tertiary Care Hospital.

249. Loss of Alpha Globin Genes in Human Subjects Is Associated with Improved Nitric Oxide-Mediated Vascular Perfusion

Catalog

Books, media, physical & digital resources